-+ 0.00%
-+ 0.00%
-+ 0.00%

Heritage Financial (HFWA) Stock Jumps After Q3 Earnings Lift Margin Hopes

Simply Wall St·10/23/2026 06:36:13
语音播报

Heritage Financial walked into this Q3 2026 report with a stock that had barely moved over the past month, then jumped about 3% to US$28.52 once traders saw the headlines. The excitement centers on a clean banking story. Earnings per share landed around US$0.46 and net income reached about US$18.7 million, backed by a solid net interest margin print near 4%. The price reaction looks like investors rewarding improving core banking economics more than chasing a quick trade, although the full credit and valuation picture is more complicated than today’s one day bounce suggests.

Like the clean net interest margin story at Heritage Financial but unsure whether this one day pop is the right place to put fresh capital to work? Compare HFWA against a curated list of banks and financials with stronger balance sheets and consistent fundamentals in our list of solid balance sheet and fundamentals stocks (26 results)

Q3 2026 Earnings Summary

  • Total Revenue (Q3 2026 vs. Q3 2025): US$84.241 million compared with US$63.921 million (increase of about 32%)
  • Net Income (Excl. Extra Items, Q3 2026 vs. Q3 2025): US$18.72 million compared with US$19.169 million (decrease of about 2%)
  • Basic EPS (Q3 2026 vs. Q3 2025): US$0.46 compared with US$0.56 (decrease of about 19%)
  • Net Interest Margin (Q3 2026 vs. Q3 2025): approximately 4.05% compared with 3.64% (expansion of about 0.41 percentage points)

Earnings grabbed the headlines for Heritage Financial, but investors who care about what they are really paying for usually follow the cash that actually comes in and out of the business. When you focus on Heritage Financial's cash flows rather than just the latest EPS line, the stock could be a dramatic 35% undervalued.

NasdaqGS:HFWA Trailing 12-Month Revenue & Expenses Breakdown as at Oct 2026
NasdaqGS:HFWA Trailing 12-Month Revenue & Expenses Breakdown as at Oct 2026

Heritage Financial’s Upside Story Faces Reality Check

Supporters argue that Heritage Financial’s integrations should unlock a leaner franchise and clearer earnings power.

"Completion of the Olympic and Kitsap integrations, including the late September systems conversion and the expected step down in quarterly noninterest expense from roughly $64 million to about $56 million to $57 million in Q4, could reveal a lower operating cost base and support higher net margins and earnings."

Q3 already shows noninterest expense down US$2.4 million, mostly from lower merger costs, with management calling out a Q4 run rate near US$55–56 million. Net interest margin at 4.05% and higher net interest income signal that the integration playbook is translating into cleaner, more profitable spread income.

Testing The Bear Case On Growth And Funding

Skeptics worry that loan churn and funding competition will undercut that brighter margin story.

"Elevated loan prepayments and payoffs, highlighted by US$152 million of payoffs in the most recent quarter and a mix shift toward construction lending where balances fund in over time, are already keeping Heritage Financial’s period end loan growth modest despite a US$628 million commercial pipeline."

Q3 confirms this friction. Loans increased US$133 million, yet payoffs climbed to US$207 million and the commercial pipeline stepped down to US$399 million. Deposit pressure is present but contained so far, with interest bearing funding at roughly 1.66% and new deposit inflows around 2%, so margin expansion currently outweighs the growth drag.

That disagreement has a full argument behind it. → Uncover the higher Fair Value this Narrative argues for.

Hunt Quiet Dislocations Before They Close

Heritage Financial just reminded you how quickly sentiment can shift when investors focus on margins. The real opportunity could be spotting stocks that look mispriced before the next earnings update resets expectations.

  • Company 1 - 23% below our estimate - builds treatment capacity and payer access for new cardiometabolic drugs targeting obesity and related chronic conditions.
  • Company 2 - 31% below our estimate - embeds custom chips and software into data infrastructure that moves and secures traffic for major cloud and enterprise clients.
  • Company 3 - 41% below our estimate - ramps advanced circuit boards and mission systems for AI data centers and defense contractors expanding key long term programs.

That is three of the list. See all 29 potentially undervalued companies →